Residential substance user treatment programs as venues for HCV pharmacological treatment: Client and staff perspectives

Shiela M. Strauss, Janetta M. Astone, Corrine Munoz-Plaza, Holly Hagan, Don Des Jarlais

Research output: Contribution to journalArticle

Abstract

Hepatitis C virus (HCV) infection is highly prevalent among drug users. While there are antiviral medications available to combat the virus, the medication regimen is quite arduous, presenting special issues for drug users. We examined the challenges and benefits of using residential substance user treatment programs as venues for clients to undergo HCV medication regimens. Analyses of qualitative data collected from clients and staff in 2003 at four residential substance user treatment programs in the U.S. indicate that challenges primarily include issues involving the medications' side effects, and both financial and communication concerns. Benefits especially involve clients' feelings that they are being proactive in addressing health issues in an environment that provides much-needed support. Findings illuminate the complex issues involved for both clients and the programs, and some steps that programs can take to better support HCV-infected clients regarding HCV medication concerns.

Original languageEnglish (US)
Pages (from-to)1811-1829
Number of pages19
JournalSubstance Use and Misuse
Volume40
Issue number12
DOIs
StatePublished - 2005

Fingerprint

Hepacivirus
contagious disease
medication
Pharmacology
staff
Drug Users
drug
Virus Diseases
Therapeutics
Antiviral Agents
Emotions
Communication
Viruses
Health
communication
health

Keywords

  • Drug users
  • HCV medication
  • Hepatitis C
  • Residential substance user treatment

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Medicine (miscellaneous)
  • Psychology(all)

Cite this

Residential substance user treatment programs as venues for HCV pharmacological treatment : Client and staff perspectives. / Strauss, Shiela M.; Astone, Janetta M.; Munoz-Plaza, Corrine; Hagan, Holly; Des Jarlais, Don.

In: Substance Use and Misuse, Vol. 40, No. 12, 2005, p. 1811-1829.

Research output: Contribution to journalArticle

@article{eb9dc628308e4af19bd463694068c656,
title = "Residential substance user treatment programs as venues for HCV pharmacological treatment: Client and staff perspectives",
abstract = "Hepatitis C virus (HCV) infection is highly prevalent among drug users. While there are antiviral medications available to combat the virus, the medication regimen is quite arduous, presenting special issues for drug users. We examined the challenges and benefits of using residential substance user treatment programs as venues for clients to undergo HCV medication regimens. Analyses of qualitative data collected from clients and staff in 2003 at four residential substance user treatment programs in the U.S. indicate that challenges primarily include issues involving the medications' side effects, and both financial and communication concerns. Benefits especially involve clients' feelings that they are being proactive in addressing health issues in an environment that provides much-needed support. Findings illuminate the complex issues involved for both clients and the programs, and some steps that programs can take to better support HCV-infected clients regarding HCV medication concerns.",
keywords = "Drug users, HCV medication, Hepatitis C, Residential substance user treatment",
author = "Strauss, {Shiela M.} and Astone, {Janetta M.} and Corrine Munoz-Plaza and Holly Hagan and {Des Jarlais}, Don",
year = "2005",
doi = "10.1080/10826080500261097",
language = "English (US)",
volume = "40",
pages = "1811--1829",
journal = "Substance Use and Misuse",
issn = "1082-6084",
publisher = "Informa Healthcare",
number = "12",

}

TY - JOUR

T1 - Residential substance user treatment programs as venues for HCV pharmacological treatment

T2 - Client and staff perspectives

AU - Strauss, Shiela M.

AU - Astone, Janetta M.

AU - Munoz-Plaza, Corrine

AU - Hagan, Holly

AU - Des Jarlais, Don

PY - 2005

Y1 - 2005

N2 - Hepatitis C virus (HCV) infection is highly prevalent among drug users. While there are antiviral medications available to combat the virus, the medication regimen is quite arduous, presenting special issues for drug users. We examined the challenges and benefits of using residential substance user treatment programs as venues for clients to undergo HCV medication regimens. Analyses of qualitative data collected from clients and staff in 2003 at four residential substance user treatment programs in the U.S. indicate that challenges primarily include issues involving the medications' side effects, and both financial and communication concerns. Benefits especially involve clients' feelings that they are being proactive in addressing health issues in an environment that provides much-needed support. Findings illuminate the complex issues involved for both clients and the programs, and some steps that programs can take to better support HCV-infected clients regarding HCV medication concerns.

AB - Hepatitis C virus (HCV) infection is highly prevalent among drug users. While there are antiviral medications available to combat the virus, the medication regimen is quite arduous, presenting special issues for drug users. We examined the challenges and benefits of using residential substance user treatment programs as venues for clients to undergo HCV medication regimens. Analyses of qualitative data collected from clients and staff in 2003 at four residential substance user treatment programs in the U.S. indicate that challenges primarily include issues involving the medications' side effects, and both financial and communication concerns. Benefits especially involve clients' feelings that they are being proactive in addressing health issues in an environment that provides much-needed support. Findings illuminate the complex issues involved for both clients and the programs, and some steps that programs can take to better support HCV-infected clients regarding HCV medication concerns.

KW - Drug users

KW - HCV medication

KW - Hepatitis C

KW - Residential substance user treatment

UR - http://www.scopus.com/inward/record.url?scp=27544440150&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=27544440150&partnerID=8YFLogxK

U2 - 10.1080/10826080500261097

DO - 10.1080/10826080500261097

M3 - Article

C2 - 16419558

AN - SCOPUS:27544440150

VL - 40

SP - 1811

EP - 1829

JO - Substance Use and Misuse

JF - Substance Use and Misuse

SN - 1082-6084

IS - 12

ER -